Search results for "TC"

showing 10 items of 9993 documents

2019

PIK3CA-related overgrowth spectrum (PROS) encompasses a range of debilitating conditions defined by asymmetric overgrowth caused by mosaic activating PIK3CA variants. PIK3CA encodes the p110α catalytic subunit of phosphatidylinositol-3-kinase (PI3K), a critical transducer of growth factor signaling. As mTOR mediates the growth-promoting actions of PI3K, we hypothesized that the mTOR inhibitor sirolimus would slow pathological overgrowth. Thirty-nine participants with PROS and progressive overgrowth were enrolled into open-label studies across three centers, and results were pooled. For the primary outcome, tissue volumes at affected and unaffected sites were measured by dual energy X-ray ab…

0301 basic medicinemedicine.medical_specialtybusiness.industrySirolimus therapyLow doseDiscovery and development of mTOR inhibitorsGastroenterology03 medical and health sciences030104 developmental biology0302 clinical medicinePrimary outcome030220 oncology & carcinogenesisSirolimusInternal medicinemedicineAsymmetric overgrowthbusinessAdverse effectPathologicalGenetics (clinical)medicine.drugGenetics in Medicine
researchProduct

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

2017

0301 basic medicinemedicine.medical_specialtyhepacivirusHCV RASTreatment outcomeDrug ResistanceHCV genotypesDrug resistanceBiologyNS5A03 medical and health sciences0302 clinical medicineSecond linedrug resistance viral; humans; retreatment; treatment outcome; antiviral agents; hepacivirus; hepatitis c chronicInternal medicineDrug Resistance Viral; Humans; Retreatment; Treatment Outcome; Antiviral Agents; Hepacivirus; Hepatitis C ChronicDrug Resistance Viralantiviral agentsmedicineViralChronicNS5AhumansHepatologyhepatitis c chronicHepatitis CHepatitis C ChronicSettore MED/07 - Microbiologia e Microbiologia Clinicamedicine.diseaseHepatitis CVirologyHepatology HCV NS5A030104 developmental biologyHCVtreatment outcome030211 gastroenterology & hepatologyretreatmentdrug resistance viral
researchProduct

Complication of endoscopic tattooing: a case report of covered perforation

2016

Aim Laparoscopy is considered a good approach in treatment of colorectal neoplastic diseases; the endoscopic tattooing is then recommended (Evidence Level III and grade of recommendation A) to mark a lesion or a polypectomy site for intraoperative identification. We describe the case of perforation after tattoing treated conservatively. Case report 63 years old woman, underwent colonoscopy for lipoma tattooing with India ink SPOT® solution kit and saline test. Immediately after the procedure the patient has been referred the appearance of colic epi-mesogastric pain and fever; Computed Tomography (CT) without MDC identified an irregular thickening of transverse colon with some microbubbles c…

0301 basic medicinemedicine.medical_specialtymedicine.medical_treatmentPerforation (oil well)ColonoscopyPeritonitisBacteremiaClinical Practice03 medical and health sciences0302 clinical medicineEnteral NutritionmedicineHumansLaparoscopyColoring AgentsPerforationmedicine.diagnostic_testTattooingbusiness.industryTransverse colonEndoscopyColonoscopyMiddle Agedmedicine.diseaseEndoscopy; Perforation; Surgery; Tattoing; SurgeryPolypectomyCarbonSurgeryEndoscopyAnti-Bacterial AgentsTattoing030104 developmental biologyTreatment OutcomeIntestinal Perforation030220 oncology & carcinogenesisSurgeryFemaleLipomabusinessComplicationColorectal NeoplasmsTomography X-Ray Computed
researchProduct

Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Sy…

2021

Abstract Purpose To determine impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) on gynecological cancer incidence and death in heterozygotes of pathogenic MMR ( path_MMR ) variants. Methods The Prospective Lynch Syndrome Database was used to investigate the effects of gynecological risk-reducing surgery (RRS) at different ages. Results Risk-reducing hysterectomy at 25 years of age prevents endometrial cancer before 50 years in 15%, 18%, 13%, and 0% of path_MLH1 , path_MSH2 , path_MSH6 , and path_PMS2 heterozygotes and death in 2%, 2%, 1%, and 0%, respectively. Risk-reducing BSO at 25 years of age prevents ovarian cancer before 50 years in 6%, 11%, 2%, and 0% and…

0301 basic medicinemedicine.medical_treatmentDNA Mismatch RepairGynecologic surgery0302 clinical medicineMalalties hereditàriesProspective StudiesProspective cohort studyGenetics (clinical)Mismatch Repair Endonuclease PMS2Incidence (epidemiology)Middle Aged16. Peace & justiceLynch syndrome3. Good health030220 oncology & carcinogenesisFemalesyöpätauditMutL Protein Homolog 1Genetic diseasesHeterozygotemedicine.medical_specialtySalpingo-oophorectomyCirurgia ginecològicaHysterectomyArticle03 medical and health sciencesCàncer colorectalCAPP2medicineHumansLynchin oireyhtymäGynecologyperinnölliset tauditHysterectomyHEREDITARY COLORECTAL-CANCERbusiness.industryEndometrial cancerCancermedicine.diseaseColorectal Neoplasms Hereditary NonpolyposisColorectal cancerASPIRIN030104 developmental biologyClinical researchLynch syndrome3121 General medicine internal medicine and other clinical medicinekohdunpoisto3111 BiomedicineOvarian cancerbusiness
researchProduct

Exosomal HSP60: a potentially useful biomarker for diagnosis, assessing prognosis, and monitoring response to treatment.

2017

Introduction: Cell-to-cell communication is imperative for life and it is mediated by sending and receiving information via the secretion and subsequent receptor-mediated detection of biological molecules. Exosomes (EXs) secreted from cells to the extracellular environment play an important role in intercellular communication in normal and pathological conditions. Areas covered: New evidence indicates that tumor cells-derived EXs contribute to cancer progression through the modulation of tumor microenvironment. The exosomal heat shock protein 60 (HSP60) is very likely a key player in intercellular cross-talk, particularly during the progress of diseases, such as cancer. Many studies have fo…

0301 basic medicinetheranostic2734BiologyExosomesPathology and Forensic Medicine03 medical and health sciencesExtracellular VesiclesImmune systemHeat shock proteinNeoplasmsGeneticsmedicineBiomarkers TumorAnimalsHumansMolecular Targeted TherapyLiquid biopsyExtracellular Vesicles (EVs)Molecular BiologyCancerTumor microenvironmentLiquid BiopsyExosomes (EXs)CancerChaperonin 60medicine.diseasePrognosisHeat Shock Protein 60 (HSP60)MicrovesiclesBiomarker030104 developmental biologyTreatment OutcomeImmunologyCancer researchMolecular MedicineHSP60BiomarkersExpert review of molecular diagnostics
researchProduct

Arabidopsis TCP Transcription Factors Interact with the SUMO Conjugating Machinery in Nuclear Foci

2017

In Arabidopsis more than 400 proteins have been identified as SUMO targets, both in vivo and in vitro. Among others, transcription factors (TFs) are common targets for SUMO conjugation. Here we aimed to exhaustively screen for TFs that interact with the SUMO machinery using an arrayed yeast two-hybrid library containing more than 1,100 TFs. We identified 76 interactors that foremost interact with the SUMO conjugation enzyme SCE1 and/or the SUMO E3 ligase SIZ1. These interactors belong to various TF families, which control a wide range of processes in plant development and stress signaling. Amongst these interactors, the TCP family was overrepresented with several TCPs interacting with diffe…

0301 basic medicineyeast two-hybridTwo-hybrid screeninggenetic processesSUMO proteinLaboratory of VirologyPlant Sciencemacromolecular substanceslcsh:Plant cultureenvironment and public healthLaboratorium voor Virologie03 medical and health sciencesArabidopsistranscription factorsTranscription factorslcsh:SB1-1110Transcription factorOriginal ResearchGeneticschemistry.chemical_classificationbiologySUMO conjugationChemistryYeast two-hybridbiology.organism_classificationIn vitroYeastCell biologyUbiquitin ligaseenzymes and coenzymes (carbohydrates)030104 developmental biologyEnzymeSUMObiology.proteinhealth occupationsEPSTCP
researchProduct

Real-life practice: rapid improvement in itch symptomatology in patients with atopic dermatitis treated with dupilumab

2019

Sir,Atopic dermatitis is a chronic relapsing inflammatory skin disorder that affects up to 20% of children and 2–5% of the adult population (1). The disease is characterized by erythematous, xeroti...

030203 arthritis & rheumatologymedicine.medical_specialtybusiness.industryAdult populationMEDLINEDermatologyAtopic dermatitisDiseasemedicine.diseaseDupilumabDermatologybody regions030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineMedicineIn patientbusinessatopic dermatitis itchJournal of Dermatological Treatment
researchProduct

Calcified Spinal Meningioma: A Lurking Danger

2017

Tumors of the spine with an intradural location have an incidence ranging from 3 to 10 per 100,000 persons per year, and intradural extramedullary tumors account for two thirds of all intraspinal neoplasms. Among these, spinal meningiomas account for 25%–46% of all spinal cord tumors. They develop from the arachnoid cells that differentiate from neural crest cells and, like cerebral meningioma, they have a slow-growing behavior. Although spinal meningiomas are not uncommon, calcified spinal meningioma is rare in spinal location. Calcified meningioma manifests with extensive matrix and tends to infiltrate the surrounding structures. It exhibits a growth pattern limited by an incompletely dev…

030203 arthritis & rheumatologymedicine.medical_specialtybusiness.industryCalcification Calcified meningioma Meningioma Ossified meningioma Outcome Spinal meningiomaCalcificationCalcified meningiomaMeningiomaOssified meningiomaOutcomeSpinal meningiomaCalcinosismedicine.diseaseThoracic VertebraeMeningioma03 medical and health sciences0302 clinical medicineMeningeal NeoplasmsmedicineHumansSurgeryNeurology (clinical)RadiologyMeningiomabusiness030217 neurology & neurosurgeryCalcificationWorld Neurosurgery
researchProduct

Glucosamine sulphate: an umbrella review of health outcomes

2020

Background and Aims:Glucosamine sulphate (GS) can be used as background therapy in people affected by knee osteoarthritis (OA). Knowledge regarding the efficacy and safety of GS is of importance since its use worldwide is increasing. Therefore, the present study aimed to map and grade the diverse health outcomes associated with GS using an umbrella review approach.Methods:Medline, Cinahl and Embase databases were searched until 1 April 2020. An umbrella review of systematic reviews and meta-analyses of randomized controlled trials (RCTs) was carried out. The evidence from the RCTs was graded using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool.Results:Fro…

030203 arthritis & rheumatologymedicine.medical_specialtyumbrella reviewbusiness.industryDiseases of the musculoskeletal systemOsteoarthritismedicine.diseaseHealth outcomesosteoarthritis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRC925-935RheumatologychemistryGlucosamineInternal medicineglucosamine sulphate; osteoarthritis; umbrella reviewglucosamine sulphateMedicineosteoarthritiOrthopedics and Sports Medicine030212 general & internal medicinebusinessMeta-Analysis
researchProduct

Can hip resurfacing be safely revised with short-stem total hip arthroplasty? A case series of six patients.

2021

Abstract Background The usage of short stems in primary total hip arthroplasty (THA) has constantly gained popularity over the last decade, however, to date, short stems are not eligible to be used as revision implants. The aim of this study was to retrospectively evaluate the outcome of revision surgery of failed hip resurfacing arthroplasty (HRA) using short-stem THA. Methods In a single center, retrospective analysis, 6 consecutive patients who were treated with a calcar-guided short stem after failure of HRA were evaluated. The mean follow-up was 3.25 years (SD 0.45). Patient reported outcome measurements (PROMs) were recorded using the Harris hip score (HHS) and The Western Ontario and…

030222 orthopedicsmedicine.medical_specialtyWOMACbusiness.industryVisual analogue scalemedicine.medical_treatment030229 sport sciencesOsteoarthritisStress shieldingmedicine.diseaseArthroplastyHip resurfacingSurgery03 medical and health sciences0302 clinical medicineHarris Hip ScoreMedicineOrthopedics and Sports MedicinePatient-reported outcomebusinessJournal of orthopaedics
researchProduct